Top Markets
Coin of the day
Neurizon Therapeutics Limited Neurizon Therapeutics Limited

Neurizon Therapeutics Limited

NUZ
Rang in aandelen #27538
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops... Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Aandeelprijs
$0.0416118
Marktkapitalisatie
$32.25M
Verandering (1 dag)
-1.67%
Verandering (1 jaar)
-59.58%
Land
AU
Handel Neurizon Therapeutics Limited (NUZ)

Categorie

Koersgeschiedenis voor Neurizon Therapeutics Limited (NUZ)
Hoogste slotkoers: $0.04 op 2026-08-01

Laagste slotkoers: $3.11 op 2001-10-01
Koersgeschiedenis van Neurizon Therapeutics Limited van 2001 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -8.62%
2025 -37.70%
2024 50.11%
2023 61.50%
2022 -33.17%
2021 -20.54%
2020 20.68%
2019 171.67%
2018 -30.35%
2017 4.90%
2016 -29.98%
2015 -55.93%
2014 -33.04%
2013 25.44%
2012 -54.31%
2011 -8.75%
2010 -46.71%
2009 152.12%
2008 -65.75%
2007 -55.38%
2006 -27.70%
2005 -34.70%
2004 20.98%
2003 69.43%
2002 -28.84%
2001 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$759.01 6.64%
CH